[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:pancreatic-ductal-adenocarcinoma:mtap-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Pancreatic Ductal Adenocarcinoma","MTAP Gene",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07283705","A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer",[12],"Phase 2","RECRUITING","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.390394Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06922591","Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:56.409949Z","2026-05-05T02:43:27.806278Z",{"nct_id":24,"title":25,"phases":26,"status":28,"updated_at":29,"content_modified":30},"NCT07076121","A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)",[27],"Phase 2\u002FPhase 3","ACTIVE_NOT_RECRUITING","2026-08-03T03:03:50.544633Z","2026-05-05T02:43:27.514544Z"]